The inhibitory effect of alendronate-hydroxyapatite composite coating on wear debris-induced peri-implant high bone turnover

Journal of Surgical Research

Volumn 179, Issue 1, 2013, Pages

  Niu, Shun ^a   Cao, Xiaorui ^a   Zhang, Yan ^a   Zhu, Qingsheng ^a   Zhu, Jinyu ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Aseptic loosening; Bisphosphonates; Bone turnover; Composite coating; Drug release; Revision

Indexed keywords

ALENDRONIC ACID; HYDROXYAPATITE; INTERSTITIAL COLLAGENASE; OSTEOCLAST DIFFERENTIATION FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; BONE DENSITY; BONE IMPLANT; BONE MINERALIZATION; BONE TURNOVER; CONTROLLED STUDY; EXPERIMENTAL RABBIT; HISTOLOGY; HYDROGEN BOND; IN VITRO STUDY; JOINT PRESSURE; MALE; MORPHOMETRICS; NONHUMAN; OSTEOLYSIS; PRIORITY JOURNAL; SYNOVIUM; TIBIA;

ALENDRONATE; ANIMALS; BONE DENSITY; CYTOKINES; DURAPATITE; MALE; MODELS, ANIMAL; ORTHOPEDICS; OSTEOLYSIS; PROSTHESES AND IMPLANTS; RABBITS; SYNOVIAL MEMBRANE; TIBIA;

EID: 84870700708     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2012.02.003     Document Type: Article

References (38)

1. M. Tanzer, D. Karabasz, and J.J. Krygier Bone augmentation around and within porous implants by local bisphosphonate elution Clin Orthop Relat Res 441 2005 30
2. B. Peter, O. Gauthier, and S. Laïb Local delivery of bisphosphonate from coated orthopedic implants increases implants mechanical stability in osteoporotic rats J Biomed Mater Res A 76 2006 133
3. R.G. Russell, N.B. Watts, and F.H. Ebetino Mechanisms of action of bisphosphonates: Similarities and differences and their potential influence on clinical efficacy Osteoporos Int 19 2008 733
4. S.J. Suratwala, S.K. Cho, and J.J. van Raalte Enhancement of periprosthetic bone quality with topical hydroxyapatite-bisphosphonate composite J Bone Joint Surg 90 2008 2189
5. C. Faucheux, E. Verron, and A. Soueidan Controlled release of bisphosphonate from a calcium phosphate biomaterial inhibits osteoclastic resorption in vitro J Biomed Mater Res A 89 2009 46
6. C.Z. Wang, S.M. Chen, and C.H. Chen The effect of the local delivery of alendronate on human adipose-derived stem cell-based bone regeneration Biomaterials 31 2010 8674
7. B. Peter, D.P. Pioletti, and S. Laïb Calcium phosphate drug delivery system: Influence of local zoledronate release on bone implant osteointegration Bone 36 2005 52
8. T. Jakobsen, S. Kold, and J.E. Bechtold Local alendronate increases fixation of implants inserted with bone compaction: 12-week canine study J Orthop Res 25 2007 432
9. K. Wermelin, P. Tengvall, and P. Aspenberg Surface-bound bisphosphonates enhance screw fixation in rats-increasing effect up to 8 weeks after insertion Acta Orthop 78 2007 385
10. K. Wermelin, F. Suska, and P. Tengvall Stainless steel screws coated with bisphosphonates gave stronger fixation and more surrounding bone. Histomorphometry in rats Bone 42 2008 365
11. V.A. Stadelmann, O. Gauthier, and A. Terrier Implants delivering bisphosphonate locally increase periprosthetic bone density in an osteoporotic sheep model. A pilot study Eur Cell Mater 16 2008 10
12. Y. Gao, E. Luo, and J. Hu Effect of combined local treatment with zoledronic acid and basic fibroblast growth factor on implant fixation in ovariectomized rats Bone 44 2009 225
13. Y. Gao, S. Zou, and X. Liu The effect of surface immobilized bisphosphonates on the fixation of hydroxyapatite-coated titanium implants in ovariectomized rats Biomaterials 30 2009 1790
14. E. Perilli, V. Le, and B. Ma Detecting early bone changes using in vivo micro-CT in ovariectomized, zoledronic acid-treated, and sham-operated rats Osteoporos Int 21 2010 1371
15. M. Iwase, K.J. Kim, and Y. Kobayashi A novel bisphosphonate inhibits inflammatory bone resorption in a rat osteolysis model with continuous infusion of polyethylene particles J Orthop Res 20 2002 499
16. P.J. Millett, M.J. Allen, and M.P. Bostrom Effects of alendronate on particle-induced osteolysis in a rat model J Bone Joint Surg 84 2002 236
17. L.M. Wise, S.D. Waldman, and M. Kasra Effect of zoledronate on bone quality in the treatment of aseptic loosening of hip arthroplasty in the dog Calcif Tissue Int 77 2005 367
18. F. von Knoch, C. Eckhardt, and C.I. Alabre Anabolic effects of bisphosphonates on peri-implant bone stock Biomaterials 28 2007 3549
19. S. Gonnelli, C. Cepollaro, and C. Pondrelli Bone turnover and the response to alendronate treatment in postmenopausal osteoporosis Calcif Tissue Int 65 1999 359
20. F.H. Ebetino, M.D. Francis, and M.J. Rogers Mechanisms of action of etidronate and other bisphosphonates Rev Contemp Pharmacother 9 1998 233
21. M. von Knoch, C. Sprecher, and B. Barden Size and shape of commercially available polyethylene particles for in-vitro and in-vivo-experiments Z Orthop Ihre Grenzgeb 142 2004 366
22. W.J. Dhert, C.C. Verheyen, and L.H. Braak A finite element analysis of the push-out test: Influence of test conditions J Biomed Mater Res 26 1992 119
23. J. Kuljanin, I. Janković, and J. Nedeljković Spectrophotometric determination of alendronate in pharmaceutical formulations via complex formation with Fe(III) ions J Pharm Biomed Anal 28 2002 1215
24. O. Rahbek, S. Overgaard, and M. Lind Sealing effect of hydroxyapatite coating on peri-implant migration of particles. An experimental study in dogs J Bone Joint Surg 83 2001 441
25. D. Santini, M.E. Fratto, and B. Vincenzi Bisphosphonate effects in cancer and inflammatory diseases: In vitro and in vivo modulation of cytokine activities BioDrugs 18 2004 269
26. J.E. Dunford, A.A. Kwaasi, and M.J. Rogers Structure-activity relationships among the nitrogen containing bisphosphonates in clinical use and other analogues: Time-dependent inhibition of human farnesyl pyrophosphate synthase J Med Chem 51 2008 2187
27. T.P. Schmalzried, K.H. Akizuki, and A.N. Fedenko The role of access of joint fluid to bone in periarticular osteolysis. A report of four cases J Bone Joint Surg 79 1997 447
28. H. Van der Vis, P. Aspenberg, and R. De Kleine Short periods of oscillating fluid pressure directed at a titanium-bone interface in rabbits lead to bone lysis Acta Orthop Scand 69 1998 5
29. G.M. Ferrier, A. McEvoy, and C.E. Evans The effect of cyclic pressure on human monocyte-derived macrophages in vitro J Bone Joint Surg 82 2000 755
30. T. Sato, T. Hara, and S. Mori Threshold for bone resorption induced by continuous and intermittent pressure in the rat hard palate J Dent Res 77 1998 387
31. G.Y. Boivin, P.M. Chavassieux, and A.C. Santora Alendronate increases bone strength by increasing the mean degree of mineralisation of bone tissue in osteoporotic women Bone 27 2000 687
32. N. Ishiguro, T. Ito, and K. Kurokouchi mRNA expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in interface tissue around implants in loosening total hip arthroplasty J Biomed Mater Res 32 1996 611
33. E. Boanini, P. Torricelli, and M. Gazzano Alendronate-hydroxyapatite nanocomposites and their interaction with osteoclasts and osteoblast-like cells Biomaterials 29 2008 790
34. F. Legay, S. Gauron, and F. Deckert Development and validation of a highly sensitive RIA for zoledronic acid, a new potent heterocyclic bisphosphonate, in human serum, plasma and urine J Pharm Biomed Anal 30 2002 897
35. M.H. Yun, and K.I. Kwon High-performance liquid chromatography method for determining alendronate sodium in human plasma by detecting fluorescence: Application to a pharmacokinetic study in humans J Pharm Biomed Anal 40 2006 168
36. J.H. Lin Bisphosphonates: A review of their pharmacokinetic properties Bone 18 1996 75
37. T. Diab, M.R. Allen, and D.B. Burr Alendronate treatment results in similar levels of trabecular bone remodelling in the femoral neck and vertebra Osteoporos Int 20 2009 647
38. H.G. Bone, D. Hosking, J.P. Devogelaer Alendronate phase III osteoporosis treatment study group Ten years' experience with alendronate for osteoporosis in postmenopausal women N Engl J Med 12 2004 1189